Table 3 Characteristics of lung cancer status among non-COPD and COPD patients
All cases (n = 270) | Non-COPD (n = 123) | COPD (n = 147) | p value | |
|---|---|---|---|---|
Pathology | 0.0001 # | |||
Adenocarcinoma | 53.7 (145) | 69.9 (86) | 40.1 (59) ## | |
Sq | 27.0 (73) | 17.9 (22) | 34.7 (52) ## | |
NSCLC | 10.4 (28) | 4.9 (6) | 15.0 (21) ## | |
SCLC | 6.7 (18) | 5.7 (7) | 7.5 (11) | |
Large | 2.2 (6) | 1.6 (2) | 2.7 (4) | |
Clinical stage | 0.046 # | |||
1A | 25.6 (69) | 30.8 (38) | 21.1 (31) | |
1B | 13.7 (37) | 13.0 (16) | 13.6 (20) | |
2A | 9.6 (26) | 13.0 (16) | 7.5 (11) | |
2B | 7.8 (21) | 9.8 (12) | 6.1 (9) | |
3A | 11.9 (32) | 8.9 (11) | 14.3 (21) | |
3B | 5.6 (15) | 4.1 (5) | 6.8 (10) | |
4 | 17.0 (46) | 16.3 (20) | 17.7 (26) | |
ND | 8.9 (24) | 4.1 (5) | 12.9 (19) ## | |
Thoracic surgery | 0.0001 # | |||
Yes | 138 (51.1) | 64.2 (79) | 40.1 (59) | |
EGFR mutation status | 0.001 # | |||
Yes | 14.8 (40) | 21.1 (26) | 9.5 (14) ## | |
No | 55.2 (149) | 59.3 (73) | 51.7 (76) | |
ND | 30.0 (81) | 19.5 (24) | 38.8 (57) ## |